{"id":"NCT01381900","sponsor":"Janssen Research & Development, LLC","briefTitle":"A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, 18-Week Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-08","primaryCompletion":"2012-11","completion":"2012-11","firstPosted":"2011-06-27","resultsPosted":"2014-01-09","lastUpdate":"2014-05-09"},"enrollment":678,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Canagliflozin 100mg","otherNames":[]},{"type":"DRUG","name":"Canagliflozin 300mg","otherNames":[]},{"type":"DRUG","name":"Metformin","otherNames":[]},{"type":"DRUG","name":"Sulphonylurea","otherNames":[]}],"arms":[{"label":"Canagliflozin 100mg","type":"EXPERIMENTAL"},{"label":"Canagliflozin 300mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the safety, tolerability, and efficacy of the addition of canagliflozin relative to the addition of placebo in patients with inadequate glycemic control on metformin alone or in combination with a sulphonylurea.","primaryOutcome":{"measure":"Change in Glycosylated Hemoglobin (HbA1c) From Baseline to Week 18","timeFrame":"Day 1 (Baseline) and Week 18","effectByArm":[{"arm":"Placebo","deltaMin":-0.47,"sd":0.096},{"arm":"Canagliflozin 100 mg","deltaMin":-0.97,"sd":0.095},{"arm":"Canagliflozin 300 mg","deltaMin":-1.06,"sd":0.095}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":4},"locations":{"siteCount":25,"countries":["China","Malaysia","Vietnam"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":226},"commonTop":["Hypoglycaemia","Upper respiratory tract infection"]}}